Press Releases

Choose a topic:
Choose year:
Media section

Abusive patenting Novartis & Co are using their “evergreening” practice to rip off the Swiss population, too

30. August 2024

40 to 90 percent profit margins Astronomical profit margins of pharmaceutical companies are partly to blame for the premium shock

12. September 2022

Trips Waiver WTO: Switzerland blocks the COVID-19 waiver until the end

10. June 2022

Patent abuse, lack of transparency, profiteering How Covid-19 exposes Big Pharma’s harmful business strategies

9. March 2021

Victory for public health Novartis drops the Kymriah patent that was opposed by Public Eye

16. December 2019

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3. July 2019

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20. May 2019

Press Release 33,000 signatures: curb the exorbitant cost of medicines

13. September 2018

Press Release Compulsory licensing in Colombia: Aggressive lobbying by Novartis

18. August 2015

Press Release Joint Open Letter Calling Novartis to cease seemingly endless legal process in India

22. February 2011

Keep up to date All our press releases by email

Media mailing list